Clinical Trials Logo

Clinical Trial Summary

The purpose of this study was to investigate whether intraarticular administration of tranexamic acid could reduce hemarthrosis and postoperative pain in patients following anterior cruciate ligament reconstruction. The hypothesis of the study was that patients treated with intraarticular tranexamic acid would have significantly less postoperative hemarthrosis and less pain in the early phase of the rehabilitation process compared with those without intraarticular tranexamic acid .


Clinical Trial Description

Intervention Based on the previous studies, intraarticular administration with concentration of 30mg/mL was selected. The operation room nurses prepared 3g tranexamic acid in 100 mL of saline solution during operation. After finishing surgical wound suture and orthopaedic surgeons related to this study left operation room, the orthopaedic residents who were not involved in the postoperative evaluation administered tranexamic acid solution through suprapatellar pouch before tourniquet release in patients in the treatment group. The control group did not receive any solution. intraarticular drain was not inserted in all patients.

Outcome Demographic variables (age, sex, body mass index, and time from injury to surgery), clinical outcomes and surgical records including operative time, bleeding amounts, meniscus and cartilage lesions were collected by an independent orthopaedic resident. Primary outcome was a blood loss calculated based on hemoglobin balance. We assumed that blood volume in ml on the second day after surgery was the same as that before surgery. Blood volume was estimated according to the method of Nadler and colleagues taking sex, body mass and height into account. The loss of Hemoglobin was then estimated according to the formula.

Hemoglobin loss=Blood volume*(Hemoglobin concentration before surgery - Hemoglobin concentration after surgery)*0.001+total amount of allogenic hemoglobin transfused

The secondary outcome was an extent of pain measured by a visual analog scale at a consistent time in the afternoon of postoperative day 1 (PD 1) and for the next 4 day.The pain visual analog scale is a numeric response on a scale from 0 to 10, with 0 denoting no pain and 10 signifying severe pain. The other secondary outcomes included mid-patellar circumference at postoperative day 2 and day 5 and knee range of motion after 6 weeks from operation, which were measured by an independent orthopaedic fellow. The patellar circumference was measured transverse axis of the patella center to evaluate intra-articular effusion. To minimize inter-observer variance of the patellar circumference, we considered the difference between the preoperative and the postoperative results. The range of motion was documented as the extension and flexion degrees using an orthopaedic goniometer. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04042688
Study type Interventional
Source Korea University Guro Hospital
Contact
Status Active, not recruiting
Phase Phase 4
Start date July 1, 2017
Completion date August 30, 2019

See also
  Status Clinical Trial Phase
Recruiting NCT05487768 - Functional Connectivity After Anterior Cruciate Ligament Reconstruction N/A
Recruiting NCT04390035 - BFRT in Adolescents After ACL Reconstruction N/A
Recruiting NCT02740452 - Anterior Cruciate Ligament Rupture N/A
Not yet recruiting NCT02555917 - Comparison of Remnant Preserving Versus Remnant Resecting Anterior Cruciate Ligament Reconstruction N/A
Active, not recruiting NCT00529958 - Comparison of Three Methods for Anterior Cruciate Ligament Reconstruction N/A
Completed NCT05109871 - Reliability and Validity of Inline Dynamometry Study for Measuring Knee Extensor Torque N/A
Not yet recruiting NCT06048874 - FNB in ACL Recon Under SA N/A
Not yet recruiting NCT06048848 - FNB in ACL Recon Under GA N/A
Terminated NCT03529552 - Evaluation After Reconstruction of the Anterior Cruciate Ligament of the Knee Using the Bioresorbable Interference Screw (SMS): Resorbability, Per- and Post-operative Complications and Articular Functional Recovery. N/A
Completed NCT04285853 - Are Opioids Needed After ACL Reconstruction Phase 4
Recruiting NCT04088227 - Effects of Platelet Rich Plasma Injections on Biomarkers After Anterior Cruciate Ligament Tears Phase 2
Active, not recruiting NCT03671421 - Number One Overall Graft Pick? Hamstring vs Bone-Patellar-Tendon-Bone vs Quadriceps Tendon N/A
Not yet recruiting NCT04957706 - Diagnostic Study of ACL Rupture With Anterior Drawer Test at 90° of Hip Flexion
Not yet recruiting NCT04953676 - A Clinical Trial of the Round-tunnel and Flat-tunnel Technique of ACL Reconstruction N/A
Enrolling by invitation NCT03365908 - Pain Management of ACL Reconstruction N/A
Recruiting NCT06030791 - BTB Graft Harvest and Donor Site Morbidity After ACL Reconstruction
Recruiting NCT03950024 - Improvement of Knowledge About the Arthrogenic Muscle Inhibition in the Aftermath of Knee Trauma. N/A
Recruiting NCT03229369 - Association of ALL and ACL Reconstruction Versus Isolated ACL Reconstruction in High-risk Population: a RCT. N/A
Completed NCT01267435 - Evaluation of Tibial and Femoral Tunnel Position After Arthroscopic Reconstruction of the Anterior Cruciate Ligament Phase 2
Recruiting NCT06430775 - Exploring Prolonged AMR in ACL Reconstructed Patients